Brain Stimulation + Cognitive Training for Mild Traumatic Brain Injury
Trial Summary
What is the purpose of this trial?
The proposed study will evaluate a new approach to cognitive rehabilitation of mTBI using a brain stimulation technique called "Remotely Supervised Transcranial Direct Current Stimulation combined with Cognitive Training" (RS-tDCS+) which has shown promise for improving complex attention in both healthy and clinical populations. RS-tDCS+ is a home-based, low-risk, non-invasive technique that is designed to boost cognitive training by enhancing learning and the brain's ability to reorganize connections. This study will evaluate RS-tDCS+ for improving complex attention in Active Duty Service Members (ADSM) and Veterans with a history of mTBI. Different tests of complex attention and symptom questionnaires will be used to determine the effects of real versus sham (placebo) RS-tDCS+. Second, the investigators will investigate electrical and connectivity changes in the brain associated with RS-tDCS+ using electroencephalogram (EEG) and magnetic resonance imaging (MRI). Third, the investigators will investigate the lasting effects of any observed changes by evaluating participants at 1 and 6 weeks post-treatment. Lastly, the investigators will explore the impact of individual differences (e.g., PTSD, depression, sleep quality, time since injury, baseline impairment, age, sex, ADSM versus Veteran) on treatment outcome.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been newly prescribed a medication within the last 3 weeks, you may not be eligible to participate.
What data supports the effectiveness of the treatment Remotely Supervised tDCS+ for mild traumatic brain injury?
Research shows that transcranial direct current stimulation (tDCS) can improve attention and cognitive function in people with traumatic brain injury. Studies have found that tDCS, especially when combined with cognitive training, helps improve working memory and reaction time, suggesting it could be a promising treatment for cognitive issues after a mild traumatic brain injury.12345
Is the Brain Stimulation + Cognitive Training treatment safe for humans?
Research shows that transcranial direct current stimulation (tDCS), including the remotely supervised version (RS-tDCS), is generally safe for humans. Studies have not reported any serious adverse effects or irreversible injuries across thousands of sessions, even in potentially vulnerable groups like children and the elderly.12678
How is the treatment RS-tDCS+ different from other treatments for mild traumatic brain injury?
RS-tDCS+ is unique because it combines brain stimulation with cognitive training, and it can be done remotely, making it more accessible and convenient. This approach is non-invasive and has shown promise in improving cognitive and emotional functions in various neurological conditions, including traumatic brain injury.2491011
Research Team
Lars D Hungerford, PhD
Principal Investigator
United States Naval Medical Center, San Diego
Eligibility Criteria
This trial is for Active Duty Service Members and Veterans who have experienced mild Traumatic Brain Injury (mTBI) and are struggling with complex attention issues. Participants should be interested in a home-based cognitive rehabilitation program using brain stimulation and cognitive training.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 sessions of cognitive training combined with transcranial direct current stimulation (RS-tDCS) over 2 weeks, conducted remotely at home.
Post-Treatment Assessment
Participants undergo post-intervention assessments including EEG and MRI to evaluate changes in brain connectivity and function.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1 and 6 weeks post-treatment.
Treatment Details
Interventions
- Remotely Supervised tDCS+ (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Naval Medical Center, San Diego
Lead Sponsor
The Defense and Veterans Brain Injury Center
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator
University of Minnesota
Collaborator
Center for Veterans Research and Education
Collaborator
General Dynamics Information Technology
Collaborator
United States Department of Defense
Collaborator